Cleveland Clinic Journal of Medicine 2007-03-01

Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.

Monica Colvin-Adams, Anne L Taylor

Index: Cleve. Clin. J. Med. 74(3) , 227-34, (2007)

Full Text: HTML

Abstract

The African American Heart Failure Trial (A-HeFT) found that African American patients with advanced heart failure fared better if the fixed-dose combination of isosorbide dinitrate and hydralazine was added to their regimen, which for most of them already included an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB), a beta-blocker, and a diuretic (N Engl J Med 2004; 351:2049-2057). This placebo-controlled trial was the first to evaluate a therapy in a specific racial group, and it points the way to a more individualized approach to heart failure therapy.

Related Compounds

  • isosorbide dinitra...

Related Articles:

In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.

2012-08-01

[Pharmazie 67(8) , 695-700, (2012)]

Superoxide dismutases, SOD1 and SOD2, play a distinct role in the fat body during pupation in silkworm Bombyx mori.

2015-01-01

[PLoS ONE 10(2) , e0116007, (2015)]

Early administration of isosorbide dinitrate improves survival of cyanide-poisoned rabbits.

2015-01-01

[Clin. Toxicol. (Phila.) 53(1) , 22-7, (2015)]

Headache response to nitrate in patients with coronary artery disease and systolic heart failure

2012-07-26

[Int. J. Cardiol. 158(3) , 453-4, (2012)]

A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.

2012-11-01

[Ann. Oncol. 23(11) , 2925-30, (2012)]

More Articles...